Abstract:Rapamycin is a triene macrolide antibiotic produced by Streptomyces hygroscopicus. Besides its wide application as an effective immunosuppressive agent, other important bioactivities have made rapamycin a potential drug lead for novel pharmaceutical development. However, the low titer of rapamycin in the original producer strain limits further industrialization efforts and restricts its use for other applications. Predicated on knowledge of the metabolic pathways related to rapamycin biosynthesis in S. hygroscopicus, we have rationally designed approaches to generate a rapamycin high producer strain of S. hygroscopicus HD-04-S. These have included alleviation of glucose repression, improved tolerance towards lysine and shikimic acid, and auxotrophy of tryptophan and phenylalanine through the application of stepwise UV mutagenesis. The resultant strain produced rapamycin at 450 mg/L in the shake flask scale. These fermentations were further scaled up in 120 and 20,000 L fermentors, respectively, at the pilot plant. Selected fermentation factors including agitation speed, pH, and on-line supplementation were systematically evaluated. A fed-batch strategy was established to maximize rapamycin production. With these efforts, an optimized fermentation process in the larger scale fermentor was developed. The final titer of rapamycin was 812 mg/L in the 120 L fermentor and 783 mg/L in the 20,000 L fermentor. This work highlights a high rapamycin producing strain derived by mutagenesis and subsequent screening, fermentation optimization of which has now made it feasible to produce rapamycin on an industrial scale by fermentation. The strategies developed here should also be applicable to titer improvement of other important microbial natural products on an industrial scale. Biotechnol. Bioeng. 2010; 107: 506-515. (C) 2010 Wiley Periodicals, Inc.

The preliminary comparison of FKBP25 in the higher sirolimus producer mutants and wild strain

FK506-binding Proteins from the Sirolimus Producer Streptomyces Hygroscopicus

Screening of higher-yield sirolimus producer, mutant FC 904-33

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Sirolimus in 3L Fermentor

SELECTION AND RAPD ANALYSIS OF A NEW SPIRULINA PLATENSIS STRAIN WITH HIGH PHYCOBILIPROTEINS CONTENTS

ABCB1 Haplotype Influences the Sirolimus Dose Requirements in Chinese Renal Transplant Recipients.

Optimization of fermentation conditions for production of a novel antifungal metabolite by response surface methodology

Comparative Metabolic Profiling Reveals the Key Role of Amino Acids Metabolism in the Rapamycin Overproduction by Streptomyces Hygroscopicus

Rational screening for high production tacrolimus-producing strain

Comparative proteomic and metabolomic analysis of Streptomyces tsukubaensis reveals the metabolic mechanism of FK506 overproduction by feeding soybean oil

Balancing carbon flux rebalancing around phosphoenolpyruvate node for enhancement of FK506 production in Streptomyces tsukubaensis

Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis.

Improved FK506 Production by the Precursors and Product-Tolerant Mutant of Streptomyces Tsukubaensis Based on Genome Shuffling and Dynamic Fed-Batch Strategies

Microbial Conversion of Sirolimus by Actinoplanes Sp. ATCC 12065

Phylogenetic Analysis of Nitrogen-Containing Macrolide Immunosuppressant Producing Streptomyces Strains

Relationship Between Different CYP3A5*3 Genotypes and Sirolimus Plasma Concentration in Chinese Renal Transplant Recipients

Comparative Metabolic Profiling-Based Improvement of Rapamycin Production by Streptomyces Hygroscopicus

Production Improvement of FK506 in Streptomyces Tsukubaensis by Metabolic Engineering Strategy

Insights into the Metabolic Mechanism of Rapamycin Overproduction in the Shikimate-Resistant Streptomyces Hygroscopicus Strain Uv-Ii Using Comparative Metabolomics

Comparative Transcriptome Analysis of Streptomyces nodosus Mutant With a High-Yield Amphotericin B